Related Experiment Video
Updated: Jun 19, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
THERAPEUTIC EXPERIMENTS WITH ROSENOW'S ANTIPOLIOMYELITIC SERUM
Rosenow's anti-poliomyelitic serum did not protect monkeys from polio-myelitis infection. Immune monkey serum, however, prevented paralysis, indicating Rosenow's serum lacks protective antibodies.
Area of Science:
- Virology
- Immunology
- Neurology
Background:
- Poliomyelitis is a serious infectious disease affecting the nervous system.
- Developing effective treatments and understanding immune responses are critical.
- Rosenow's anti-poliomyelitic serum was investigated for its therapeutic potential.
Purpose of the Study:
- To compare the efficacy of Rosenow's anti-poliomyelitic serum with immune serum from recovered monkeys.
- To determine if Rosenow's serum contains protective antibodies against poliomyelitis.
- To evaluate the therapeutic effects of these sera in experimental models.
Main Methods:
- Experiments involved introducing active poliomyelitis virus into monkey blood.
- Two types of serum were injected into the cerebrospinal meninges: Rosenow's serum and immune monkey serum.
- Control groups received either no serum or normal horse serum.
Main Results:
- Monkeys receiving Rosenow's serum developed paralysis, similar to those receiving normal horse serum.
- Monkeys receiving immune monkey serum did not develop paralysis.
- Rosenow's serum appeared to promote virus passage into nervous organs without providing protection.
Conclusions:
- Rosenow's anti-poliomyelitic serum was ineffective therapeutically in monkeys.
- The serum lacks antibodies comparable to those found in convalescent poliomyelitis serum from monkeys and humans.
- Immune monkey serum demonstrated protective capabilities against experimental poliomyelitis.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Related Concept Videos
Poliomyelitis
Respiratory Syncytial Virus Disease